TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Tuesday, April 3, 2007

A New Type of Drug Ad

I'm not going to say much about it since I'm involved in other Cox-2 litigation, but coverage of the new Pfizer ads for Celebrex certainly are interesting, as is the ad itself.  The ads are 150 seconds long, with the risk fair balance content first and rather specific, expressly referencing death as a potential side effect of any NSAID.

Products Liability | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference A New Type of Drug Ad:

» Defensive advertising from PointOfLaw Forum
Bloomberg reports that Pfizer is premiering a two-and-a-half-minute commercial (via Childs) for its COX-2 Celebrex that acknowledges that all NSAIDs have cardiovascular risks, and then argues that the benefits of Celebrex exceed the risks. The advertis... [Read More]

Tracked on Apr 3, 2007 5:52:03 AM


Post a comment